NEW YORK (
CHANGE IN RATINGS
downgraded at Goldman from Buy to Neutral. $59 price target. Valuation call, as BMY appears more attractive in the near term.
upgraded at Goldman to Buy. $25 price target. Sales finally appear to be turning around.
upgraded at Goldman to Buy. $30 price target. Company has a solid showing at ASCO and has a robust pipeline.
upgraded at Jefferies from Hold to Buy. $63 price target. Stock is down 18% since March, and the company is seeing good feedback from ASCO.
downgraded at Goldman to Sell. Business turnaround appears to be leveling off. $10 price target.
Stocks Under $5 Top 10 Buy-Rated Stocks Under $5
upgraded at Auriga from Hold to Buy. $27 price target. Estimates also boosted, as the company appears positioned well in datacenter.
Dun & Bradstreet
initiated at Piper Jaffray. Initiated with a Neutral rating and $80 price target. Introduces 2010 EPS estimates of $5.50.
downgraded at Morgan Stanley from Equal-weight to Underweight. Estimates also cut, as lower-priced casual dining restaurants could lag peers in a recovery. $17 price target.
upgraded at Morgan Joseph to Buy. $21 price target. Valuation call, as theater growth should accelerate.
rated new Buy at UBS. $43 price target. Company is seeing renewed growth momentum.
National Oilweill Varco
upgraded at Credit Suisse to Outperform from Neutral on improving floating rid orders. Price target trimmed by a dollar to $49.
downgraded at Ticonderoga from Buy to Neutral. Consumer-oriented portfolio has higher potential downside risk in the coming quarters.
STOCK COMMENTS / EPS CHANGES
cut from Conviction Buy List at Goldman. $35 price target. Stock may struggle, given higher fears of macro deceleration.
estimates higher at Credit Suisse. 2010, 2011, and 2012 EPS estimates increased to $1.13, 1.22, and $1.33, respectively. Maintain Underperform rating and $10 price target.
price target trimmed at Barclays. FSLR price target cut to $126 from $150. Currency weakness offset by better than expected fundamentals. Maintain Equal Weight rating.
estimates, target raised at Goldman. Shares of NAV now seen reaching $55. Estimates also increased, as orders have seen a sharp recovery over the past two months. Neutral rating.
estimates increased at Goldman through 2012. Company is buying back stock faster than expected. Buy rating.
target upped at Collins Stewart. Shares of OXY now seen reaching $91. Company should generate better production growth, while keeping a lid on costs. Hold rating.
This article was written by a staff member of TheStreet.com.